참고문헌
- Shammas NW. An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors. Int J Angiol 2013;22:1-8. https://doi.org/10.1055/s-0032-1331840
- Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012;59:16-23. https://doi.org/10.1016/j.jacc.2011.09.036
- Ko YG, Ahn CM, Min PK, et al. Baseline characteristics of a retrospective patient cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry. Korean Circ J 2017;47:469-76. https://doi.org/10.4070/kcj.2017.0020
- Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-54. https://doi.org/10.1161/01.CIR.94.6.1247
- Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8. https://doi.org/10.1161/01.CIR.100.18.1872
- Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5. https://doi.org/10.1016/j.jacc.2004.11.026
- Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011;4:495-504. https://doi.org/10.1161/CIRCINTERVENTIONS.111.962324
- Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-76. https://doi.org/10.1161/CIRCINTERVENTIONS.109.903468
- Shishehbor MH. Endovascular treatment of femoropopliteal lesions: so many options, little consensus. J Am Coll Cardiol 2015;66:2339-42. https://doi.org/10.1016/j.jacc.2015.09.062
- Byrne RA, Joner M, Alfonso F, et al. Drug-coated balloon therapy in coronary and peripheral artery disease. Nat Rev Cardiol 2014;11:13-23. https://doi.org/10.1038/nrcardio.2013.165
- Cassese S, Byrne RA, Ott I, et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv 2012;5:582-9. https://doi.org/10.1161/CIRCINTERVENTIONS.112.969972
- Krankenberg H, Tübler T, Ingwersen M, et al. Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized Femoral Artery In-stent Restenosis (FAIR) trial. Circulation 2015;132:2230-6. https://doi.org/10.1161/CIRCULATIONAHA.115.017364
- Kinstner CM, Lammer J, Willfort-Ehringer A, et al. Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial. JACC Cardiovasc Interv 2016;9:1386-92. https://doi.org/10.1016/j.jcin.2016.04.012
- Stabile E, Virga V, Salemme L, et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012;60:1739-42. https://doi.org/10.1016/j.jacc.2012.07.033
- Virga V, Stabile E, Biamino G, et al. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv 2014;7:411-5. https://doi.org/10.1016/j.jcin.2013.11.020
- Liistro F, Angioli P, Porto I, et al. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther 2014;21:1-8. https://doi.org/10.1583/13-4420R.1
- Grotti S, Liistro F, Angioli P, et al. Paclitaxel-eluting balloon vs standard angioplasty to reduce restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: three-year results of the DEBATE-ISR study. J Endovasc Ther 2016;23:52-7. https://doi.org/10.1177/1526602815614555
- Brodmann M, Keirse K, Scheinert D, et al. Drug-coated balloon treatment for femoropopliteal artery disease: the IN.PACT global study de novo in-stent restenosis imaging cohort. JACC Cardiovasc Interv 2017;10:2113-23. https://doi.org/10.1016/j.jcin.2017.06.018
- Bosiers M, Deloose K, Keirs K, et al. Prevention and treatment of in-stent restenosis. J Cardiovasc Surg (Torino) 2010;51:591-8.
- Gorgani F, Telis A, Narakathu N, et al. Long-term outcomes of the Viabahn stent in the treatment of in-stent restenosis in the superficial femoral artery. J Invasive Cardiol 2013;25:670-4.
- Zeller T, Dake MD, Tepe G, et al. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. JACC Cardiovasc Interv 2013;6:274-81.
- Tomoi Y, Soga Y, Iida O, et al. Impact of drug-eluting stent implantation for femoropopliteal in-stent occlusion. J Endovasc Ther 2016;23:461-7. https://doi.org/10.1177/1526602816639721
- Murata N, Takahara M, Soga Y, et al. Drug-eluting stent vs percutaneous transluminal angioplasty for treatment of femoropopliteal in-stent restenosis: results from a retrospective 1-year multicenter study. J Endovasc Ther 2016;23:642-7. https://doi.org/10.1177/1526602816642195
- Katsanos K, Spiliopoulos S, Reppas L, et al. Debulking atherectomy in the peripheral arteries: is there a role and what is the evidence? Cardiovasc Intervent Radiol 2017;40:964-77. https://doi.org/10.1007/s00270-017-1649-6
- Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv 2015;8:92-101. https://doi.org/10.1016/j.jcin.2014.09.009
- Laird JR Jr, Yeo KK, Rocha-Singh K, et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv 2012;80:852-9. https://doi.org/10.1002/ccd.23475
- Shammas NW, Shammas GA, Banerjee S, et al. JetStream rotational and aspiration atherectomy in treating in-stent restenosis of the femoropopliteal arteries: results of the JETSTREAM-ISR feasibility study. J Endovasc Ther 2016;23:339-46. https://doi.org/10.1177/1526602816634028
- Sixt S, Carpio Cancino OG, Treszl A, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg 2013;58:682-6. https://doi.org/10.1016/j.jvs.2013.02.019
- Gandini R, Del Giudice C, Merolla S, et al. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther 2013;20:805-14. https://doi.org/10.1583/13-4308MR.1
피인용 문헌
- Randomized controlled trial of orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for treatment of femoropopliteal artery in-stent restenosis vol.38, pp.5, 2019, https://doi.org/10.23736/s0392-9590.19.04243-3
- Baseline local hemodynamics as predictor of lumen remodeling at 1-year follow-up in stented superficial femoral arteries vol.11, pp.1, 2018, https://doi.org/10.1038/s41598-020-80681-8